Related Experiment Video
Updated: Jun 12, 2026

07:39
Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model
Published on: August 4, 2023
Corneal involvement in congenital aniridia
Ulla Edén1, Ruth Riise, Kristina Tornqvist
1Department of Ophthalmology, Lund University, Sweden. ulla.eden@gmail.com
Cornea
|June 23, 2010
Summary
Congenital aniridia patients often develop keratopathy, with severity increasing with age and intraocular surgery. This condition can also lead to reduced corneal sensitivity and impaired vision.
Area of Science:
- Ophthalmology
- Corneal Diseases
Background:
- Congenital aniridia is a rare genetic disorder characterized by the absence of the iris.
- Patients with aniridia are prone to developing various ocular complications, including keratopathy.
Purpose of the Study:
- To investigate the prevalence and severity of keratopathy in patients with congenital aniridia.
- To determine the correlation between keratopathy and factors such as age, intraocular surgery, and corneal sensitivity.
Main Methods:
- A comprehensive search identified 181 patients with aniridia in Sweden and Norway; 124 were clinically examined.
- Ophthalmologic examinations, including slit lamp assessment and medical history review, were performed to evaluate keratopathy.
- Eyes with artificial implants or transplants were excluded from the analysis.
Main Results:
- Visible keratopathy was present in 80% of examined eyes, with 26% experiencing visual impairment.
- A significant correlation was found between keratopathy severity and patient age.
- Intraocular surgery and reduced corneal sensitivity were significantly correlated with increased keratopathy, independent of age.
Conclusions:
- Congenital aniridia is strongly associated with keratopathy, affecting 80% of patients and impairing vision in 26%.
- Keratopathy progression is linked to advancing age, intraocular surgical procedures, and diminished corneal sensitivity.
- Careful patient selection for intraocular surgery is crucial to mitigate the risk of triggering or exacerbating keratopathy.

